Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Chibale

Showing results (311-320 of 315) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 315 results.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Journal of Medicinal Chemistry|February 12, 2021
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization EffortsClaire Le Manach, Jean Dam, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Pageof 32

Showing results (311-320 of 315) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 315 results.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Journal of Medicinal Chemistry|February 12, 2021
Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization EffortsClaire Le Manach, Jean Dam, John G Woodland, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|October 26, 2018
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria"Christel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Pageof 32